ÂÜÀòÂÒÂ×

Robert Gallotto has a strong and extensive work experience spanning several companies and roles within the biopharmaceutical industry. Most recently, they served as the President and Chief Executive Officer at Anagram Therapeutics, Inc. since April 2023. Prior to that, they held the same position at Synspira Therapeutics from an unspecified time in 2019 until April 2023.

Before their role at Synspira Therapeutics, Gallotto was a Senior Adviser and Co-founder at Alcresta Therapeutics from May 2017 to an unspecified time in 2018. Robert also held the position of President and Co-founder at Alcresta Therapeutics from an unspecified time in 2011 until an unspecified time in 2017.

Furthermore, Gallotto was the Chief Operating Officer and Co-founder at Allena Pharmaceuticals from an unspecified time in 2011 until an unspecified time in 2015. Robert also worked as the Chief Business Officer at Alnara Pharmaceuticals, Inc. from an unspecified time in 2008 until an unspecified time in 2011.

In addition, Gallotto gained experience as the Vice President of Strategic Planning & Business Development at Altus Pharmaceuticals from an unspecified time in 2001 until an unspecified time in 2008. Prior to that, they served as the Vice President of Marketing & Business Development at Sage Biopharma from an unspecified time in 1998 until an unspecified time in 2001.

Gallotto started their career as a Product Manager at Biogen from an unspecified time in 1997 until an unspecified time in 1998. Robert also worked as a Director of Marketing at Ares Serono from an unspecified time in 1995 until an unspecified time in 1997.

Overall, Robert Gallotto has held various high-level positions within the biopharmaceutical industry, displaying strong leadership and strategic expertise throughout their career.

Robert Gallotto attended Dom Savio from 1979 to 1983. Robert then pursued a Bachelor of Science degree in Biology Chemistry from Stonehill College, where they studied from 1983 to 1987.